A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KH

Views
A ...841

Total Visits Per Month

November 2021December 2021January 2022February 2022March 2022April 2022May 2022
A ...341521218110

File Visits

Views
29FL5e9GFDkgQ.pdf309